Nantahala Capital Management »

Edgewise Therapeutics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Edgewise Therapeutics (EWTX) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Edgewise Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Edgewise Therapeutics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Edgewise Therapeutics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $244k 13k 18.24

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr Ser Tr S&p Biotech (XBI)
Establishment Labs Holdings Ord (ESTA)
Soleno Therapeutics (SLNO)
Eli Lilly & Co. Put Option (LLY)
Grand Canyon Education Put Option (LOPE)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Evolus (EOLS)
Peloton Interactive Cl A Com (PTON)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)
Bioventus Com Cl A (BVS)
Rumbleon Com Cl B (RMBL)
Ishares Tr U.s. Real Es Etf Put Option (IYR)

View all positions for Nantahala Capital Management

Top funds holding Edgewise Therapeutics

OrbiMed Advisors
RA Capital Management
FMR
Baker Bros. Advisors
BlackRock
Vanguard Group
Viking Global Investors
Frazier Life Sciences Management
Cormorant Asset Management
Deerfield Management Company
Citadel Advisors
Paradigm Biocapital Advisors
Perceptive Advisors
VR Adviser
Henderson Group

View all funds holding Edgewise Therapeutics